Literature DB >> 22262662

Term neonates receiving intensive care at high risk of brainstem auditory impairment.

Zedong Jiang1, Dorathea Brosi, Rong Yin, Andrew R Wilkinsin.   

Abstract

Functional integrity of the auditory brainstem was examined using maximum length sequence brainstem auditory evoked response in 72 term neonates who were receiving intensive care. Compared with normal term controls, the neonates receiving intensive care showed an increase in wave V latency and I to V and III to V interpeak intervals of the response. Wave V latency was significantly increased at very high click rates 455 and 910/s. I to V and III to V intervals were significantly increased at all 91 to 910/s, particularly 455 and 910/s, while I to III intervals were slightly increased. III to V/I to III interval ratios were increased at 455 and 910/s clicks. The slopes of wave V latency-rate, I to V interval-rate, III to V interval-rate and III to V/I to III-interval-ratio-rate functions were significantly steeper than in normal controls. These abnormalities suggest that neonates receiving intensive care are at high risk of brainstem, mainly more central regions, auditory impairment. The MLS BAER abnormalities and brainstem auditory impairment might be the result of collective adverse effects, produced by more than one perinatal risk factor.

Entities:  

Mesh:

Year:  2012        PMID: 22262662     DOI: 10.1136/fetalneonatal-2011-301200

Source DB:  PubMed          Journal:  Arch Dis Child Fetal Neonatal Ed        ISSN: 1359-2998            Impact factor:   5.747


  2 in total

1.  Neural conduction abnormality in the brain stem and prevalence of the abnormality in late preterm infants with perinatal problems.

Authors:  Ze Dong Jiang
Journal:  Eur J Pediatr       Date:  2013-04-05       Impact factor: 3.183

2.  Brainstem shape is affected by clinical course in the neonatal intensive care unit.

Authors:  Marcus Lo; Leire Zubiaurre-Elorza; Conor Wild; Annika C Linke; David S C Lee; Victor K Han; Rhodri Cusack
Journal:  Neuroimage Clin       Date:  2017-04-12       Impact factor: 4.881

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.